Arbutus Biopharma SG&A Expense (Quarterly) Insights

Arbutus Biopharma Corp (ABUS)

3.29 +0.01 (+0.30%) USD | NASDAQ | May 24, 16:00

3.285 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	5.312M
December 31, 2023	5.101M
September 30, 2023	5.842M
June 30, 2023	5.98M
March 31, 2023	5.552M
December 31, 2022	4.249M
September 30, 2022	3.493M
June 30, 2022	5.20M
March 31, 2022	4.892M
December 31, 2021	4.597M
September 30, 2021	4.183M
June 30, 2021	4.478M
March 31, 2021	3.878M
December 31, 2020	3.661M
September 30, 2020	4.065M
June 30, 2020	3.566M
March 31, 2020	3.553M
December 31, 2019	1.877M
September 30, 2019	3.249M
June 30, 2019	8.189M
March 31, 2019	4.412M
December 31, 2018	5.927M
September 30, 2018	2.631M
June 30, 2018	3.775M
March 31, 2018	3.669M

Date	Value
December 31, 2017	3.543M
September 30, 2017	3.659M
June 30, 2017	4.599M
March 31, 2017	4.328M
December 31, 2016	4.733M
September 30, 2016	3.72M
June 30, 2016	23.77M
March 31, 2016	7.219M
December 31, 2015	8.354M
September 30, 2015	7.706M
June 30, 2015	7.662M
March 31, 2015	2.716M
December 31, 2014	3.082M
September 30, 2014	1.764M
June 30, 2014	1.787M
March 31, 2014	2.05M
December 31, 2013	2.845M
September 30, 2013	0.96M
June 30, 2013	0.849M
March 31, 2013	0.893M
December 31, 2012	21.06M
September 30, 2012	1.529M
June 30, 2012	2.363M
March 31, 2012	1.826M
December 31, 2011	2.200M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.877M

Minimum

Dec 2019

8.189M

Maximum

Jun 2019

4.546M

Average

4.364M

Median

SG&A Expense (Quarterly) Benchmarks